Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2019-07-03 Director's Dealing
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2019-07-03 English
FORM 4 SUBMISSION
Director's Dealing
2019-07-03 English
FORM 4 SUBMISSION
Director's Dealing
2019-06-19 English
FORM 4 SUBMISSION
Director's Dealing
2019-06-06 English
FORM SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the year ended December 31, 2018. It references Rule 13p-1 under the Securities Exchange Act and includes a Conflict Minerals Report as an exhibit. The document length is 3246 characters, which is relatively short and primarily serves as a disclosure filing rather than a full financial or management report. Form SD filings are specialized regulatory disclosures about conflict minerals and do not fall under annual reports, earnings releases, or other financial filings. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-05-30 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 28, 2019, reporting on events that occurred on May 22, 2019. The content includes the approval of an amendment to the company's stock incentive plan, election of directors, ratification of the independent auditor, and advisory votes on executive compensation. It provides detailed voting results from the annual meeting of stockholders. The document does not contain financial statements or comprehensive financial data but focuses on governance matters and shareholder voting outcomes. This aligns with announcements of voting results at a shareholder meeting rather than the meeting materials themselves or a full annual report. Therefore, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (8210 characters) is sufficient to include detailed voting results, supporting this classification with high confidence.
2019-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.